Table 3.

Advantages of surrogate end point studies

Sound and rational relationships with cardiovascular and renal hard end points
Require smaller number of patients and shorter duration
Provide insight into the mechanisms of disease
Provide scientific evidence for concentrating the therapeutic efforts on specific patients
Reduce the cost-benefit ratio of treatment